HCPCS Level IIdrugActive
J1952
Leuprolide inj, camcevi, 1mg
BETOS: O1D
Effective: 2022-10-01
Referenced in 2 policies
Description
Leuprolide injectable, camcevi, 1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Camcevi
Manufacturer
Accord BioPharma, Inc
HCPCS Dosage
1 MG
Billing Units
42.0000
2
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.